Patients considering discontinuation should engage in thorough discussions with their healthcare providers about realistic expectations and alternative management strategies, with follow-up monitoring within 4-12 weeks after any treatment change
It is the only GHRH analogue with a full Phase 3 dossier and an active FDA approval, its pharmacology is well-characterized across two decades of clinical work, and its dosing protocol is standardized at 2 mg subcutaneously once daily at bedtime
Peptides 17:1075-1077
A: Recommended storage is -20C under light-protected and sterile conditions
If soft, we suggest placing the Detoxamin suppository in the refrigerator for about 10 minutes before use, to firm up the suppository before usage
Ozempic Lawsuits allege that manufacturers Novo Nordisk and Eli Lilly, which also produces GLP-1 drugs, failed to adequately warn users about the potential for severe side effects such as gastroparesis (a condition causing delayed stomach emptying), intestinal obstruction, and other gastrointestinal injuries associated with these medications
